+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Methods in iPSC Technology. Advances in Stem Cell Biology

  • Book

  • June 2021
  • Elsevier Science and Technology
  • ID: 5275374

The series Advances in Stem Cell Biology is a timely and expansive collection of comprehensive information and new discoveries in the field of stem cell biology.

Methods in iPSC Technology, Volume 9 addresses the different methods used for induced pluripotent stem cell (iPSC) formation, maintenance, expansion, and differentiation.

The ability to reprogram different cell types to iPSCs offers an opportunity to generate pluripotent patient-specific cell lines that can help in the understanding of multiple human disorders. This volume addresses a variety of current methods used in the generation and manipulation of iPSCs, such as magnetic nanoparticles, piggyBac vectors, lentiviral vectors, bioscaffolds, somatic cell nuclear transfer, CRISPR/Cas9, bacteria, and much more.

This volume is written for researchers and scientists interested in stem cell therapy, cell biology, regenerative medicine, and organ transplantation and is contributed by world-renowned authors in the field.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Current Reprogramming Methods to Generate High Quality iPSCs
2. Using Magnetic Nanoparticles in iPSCs
3. PiggyBac Vectors in Pluripotent Stem Cell Research and Applications
4. Lentiviral Vectors as The Delivery Vehicles for Transduction into iPSCs: Shortcomings and Benefits
5. Decellularized Liver Extracellular Matrix for iPSC-based Liver Engineering
6. Combining Bioscaffolds and iPCSs in the Treatment of Neural Trauma and Alzheimer's disease
7. Emerging Strategies for Scalable Human Induced Pluripotent Stem Cell and Expansion and Differentiation
8. One Plus One Could be Greater than Two: Combining the Powers of Somatic Cell Nuclear Transfer with Yamanaka's Factors in Generating Clinical Grade Human Pluripotent Stem Cells
9. Bacteria to Form Induced Pluripotent Stem Cells
10. CRISPR/Cas9 Technologies to Manipulate Human Induced Pluripotent Stem Cells
11. Scalable Expansion of Human Pluripotent Stem Cells for Biomanufacturing Cellular Therapeutics
12. Xeno-Free Cultivation of Human Induced Pluripotent Stem Cells for Clinical Applications

Authors

Alexander Birbrair Department of Pathology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
Department of Radiology, Columbia University Medical Center, Medical Center, USA. Dr. Alexander Birbrair received his bachelor's biomedical degree from Santa Cruz State University in Brazil. He completed his PhD in Neuroscience, in the field of stem cell biology, at the Wake Forest School of Medicine under the mentorship of Osvaldo Delbono. Then, he joined as a postdoc in stem cell biology at Paul Frenette's laboratory at Albert Einstein School of Medicine in New York. In 2016, he was appointed faculty at Federal University of Minas Gerais in Brazil, where he started his own lab. His laboratory is interested in understanding how the cellular components of different tissues function and control disease progression. His group explores the roles of specific cell populations in the tissue microenvironment by using state-of-the-art techniques. His research is funded by the Serrapilheira Institute, CNPq, CAPES, and FAPEMIG. In 2018, Alexander was elected affiliate member of the Brazilian Academy of Sciences (ABC), and, in 2019, he was elected member of the Global Young Academy (GYA), and in 2021, he was elected affiliate member of The World Academy of Sciences (TWAS). He is the Founding Editor and Editor-in-Chief of Current Tissue Microenvironment Reports, and Associate Editor of Molecular Biotechnology. Alexander also serves in the editorial board of several other international journals: Stem Cell Reviews and Reports, Stem Cell Research, Stem Cells and Development, and Histology and Histopathology.